Inspire120-logo

Founders Longevity Forum Singapore 2025: Unlocking Healthy Longevity

Published: 06 Mar 2025

Prof Andrea Maier, Co-Director, Academy for Healthy Longevity, NUS Medicine, and Phil Newman, CEO & Founder, Longevity.Technology, delivered the welcome address at the Founders Longevity Forum Singapore 2025 

Themed ‘Unlock Healthy Longevity’, the Founders Longevity Forum Singapore 2025 welcomed 400 global longevity leaders, clinicians, academics, and investors to explore the latest advancements in precision geromedicine and longevity investment, over two days from 27 to 28 February 2025. Organised by Founders Forum Group, Longevity.Technology, and the Academy for Healthy Longevity, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), the forum served as a catalyst for driving innovation and investment in longevity science and medicine. 

Key takeaways from the conference include the following: 

  • Healthy longevity is actionable today—scientific advancements and interventions hold immense potential for clinical application; 
  • Investment in longevity is gaining momentum, signaling strong growth and interest in the field; and 
  • Collaborating with leaders and other visionaries reinforced the importance of interdisciplinary efforts in shaping the longevity landscape. 

Prof Andrea Maier, Co-Director, Academy for Healthy Longevity, NUS Medicine, gave a presentation on precision geromedicine research, titled “The Realisation of Prevention” 

A panel discussion on today’s market opportunities in consumer longevity, by (from left) Phil Newman (CEO & Founder, Longevity.Technology), Vishal Harnal (Managing Partner, 500 Global), and Luc Aguilar (Chief Scientific Officer, Advanced Research, L’Oréal R&I)  

Day 1 Highlights: Precision Geromedicine & Longevity Investment 

The first day focused on the emerging field of precision geromedicine, emphasising the role of biomarkers, diagnostics, and systems biology as key drivers in longevity research. Speakers also discussed evidence-based interventions to extend healthspan, and the integration of artificial intelligence (AI)-powered decision support systems in precision medicine. 

Another track of discussions at the forum explored the investment landscape, with a spotlight on longevity startups and investment trends. Speakers discussed opportunities in longevity clinics, diagnostics, biohacking, biotech, and wellness industries. Discussions also addressed the risks involved and strategies for scaling businesses within this field. 

From plenary sessions to specialised investment tracks, Day 1 set the stage for a data-driven and financially sustainable longevity industry. 

Day 2 Highlights: Expanding Longevity Science & Clinical Applications 

For the second day, the speakers explored a range of topics that are pushing the boundaries of ageing research and offering new possibilities for healthspan extension. Sessions delved into interventions aimed at preventing cognitive decline and enhancing cellular function. Research on brain and skin ageing, along with mitochondrial health, revealed promising approaches for maintaining vitality and function as we age. 

The sessions also covered topics on microbiome and longevity, where the role of the gut in maintaining healthspan was unpacked. Discussions on gerotherapeutics and healthcare integration looked at advancing age-related interventions and real-world implementation to make longevity treatments accessible to the broader population. The forum also explored the implementation of precision geroscience – focused on translating diagnostics, biomarkers, and interventions into clinical practice. 

A key highlight of the forum was the Rising Star Competition, which showcased next-generation researchers who are driving longevity breakthroughs. The winners of the competition are: 

  • First Prize: Jessica Lu (PhD candidate, Academy for Healthy Longevity, NUS Medicine)
    Discussed insights on digital biomarkers of ageing, using wearable technology to track physical systems in community-dwelling adults.  
  • Second Prize: Dr Ajla Hodzic Kuerec (Research Fellow, Academy for Healthy Longevity, NUS Medicine)
    Explored how fucoidan supplementation could help reduce cognitive decline and improve ageing biomarkers in pre-frail middle-aged to older men.  
  • Third Prize: Dr Weilan Wang (Research Fellow, Academy for Healthy Longevity, NUS Medicine)
    Explored how a combination of potential geroprotective drugs may enhance survival outcomes in geriatric rehabilitation inpatients. 

The forum concluded with a clear message—longevity science is not solely about extending lifespan, but ensuring those additional years are lived in optimal health. The Founders Longevity Forum Singapore showcased the incredible momentum in longevity medicine and investment. As this field evolves, the organisers look forward to continued collaboration and the translation of scientific breakthroughs into real-world impact.

Latest Updates